Flotek lifts 2026 guidance amid Q3 revenue surge and Data Analytics growth
Nov 3, 2026, 5:53 PM EST1 sourcesAI-analyzed
Why it may matterVerify against the original reporting
Surging revenue, raised full-year guidance, and a funded expansion plan reduce near-term uncertainty and may attract multiple expansion. The strength in Data Analytics and international Chemistry offsets legacy SG&A costs; debt financing supports 2027 capex, though execution risk remains.
AI summary
What happened, with direct paths to the underlying reporting
Flotek reported Q3 2026 revenue of $114.4M, up 104% YoY, driven by Data Analytics and Chemistry segments. International Chemistry grew to $28.4M; related-party revenues exceeded $50M under the ProFrac agreement. The company raised full-year guidance to $382-390M and plans $15-20M capex in 2027 to expand data assets.
FTK Q3 revenue 114.4M, up 104% YoY; two segments drive growth.
Data Analytics revenue up 104% YoY; Chemistry international sales rose.
Term loan closed in September funds Data Analytics capex expansion.
2026 guidance raised to 382-390M; Adjusted EBITDA 59-62M.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.
Related signals
More source-backed signals connected by company or event
FTK faces a securities-class action alleging misstatements about a PREPA project and related revenue risk. Wolfpack Research asserts the 400 MW PREPA contract was canceled, implyi…